News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Tari Leslie
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
4
| Tari Leslie (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $0.97, valued at
$9.7k
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2023 |
4
| Tari Leslie (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 7,562 shares
@ $1.53, valued at
$11.6k
|
|
| 01/27/2023 |
4
| Tari Leslie (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 11,814 shares
@ $1.2, valued at
$14.2k
|
|
| 09/13/2022 |
4
| Tari Leslie (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 18,159 shares
@ $0.6849, valued at
$12.4k
|
|
| 04/04/2022 |
4
| Tari Leslie (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 52,500 shares
@ $0
Granted 105,000 options to buy
@ $0.83, valued at
$87.2k
|
|
| 01/07/2022 |
4
| Tari Leslie (Chief Scientific Officer) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 1,252 shares
@ $1.25, valued at
$1.6k
Exercised 2,101 restricted stock units
@ $0 |
|
| 10/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|